Jim Rogers on love, loss and living well with younger-onset dementia
At the memory clinic, Jim Rogers is asked to reach out and touch his husband's left cheek with his right hand.
He does the opposite — left hand, right cheek — and Tyler starts crying, because he knows something is very wrong.
Jim, whose life has been shaped by searing loss and serendipitous love, was soon diagnosed with younger-onset Alzheimer's disease.
"It's the most horrific, evil disease," Jim tells Australian Story, "but you can live well with dementia."
About 410,000 Australians are living with dementia — a number predicted to double by 2058 — and Jim hopes to reduce the stigma surrounding the condition.
The 58-year-old co-hosts a podcast with broadcaster Hamish Macdonald, whose own father died from dementia last year.
"I have learned that life is not over the minute you get a diagnosis — there is joy to be had," Hamish says.
But while Jim puts on a brave face, his family says the cracks are starting to show.
"We're on a train track to hell, and there's no stopping the train," his daughter Millie says.
Before there was Jim and Tyler, there was Jim and Lorna.
The "true soulmates" married in their hometown in central England in 1989, and children followed in quick succession: first Millie, then Harvey, then Daisy.
"We had three under three, so we had our work cut out for us," Jim says.
In 1996 they moved to Perth in search of adventure — but two years in, an irritating mole on Lorna's calf turned out to be melanoma.
After her surgery they returned to the UK to be closer to family, but six months later, Lorna found a lump.
The prognosis wasn't years, or months, or even weeks — but just days.
"It was unbelievable. This stuff happens in a film, and we were just normal folks," Jim says.
Lorna died in January 1999.
When Jim told their three little kids that Mum wasn't coming home, they didn't believe him.
Six-year-old Millie thought it was a game of hide-and-seek, and went off to find her.
"It was so heart-wrenching to destroy that innocence in a child," Jim says.
Jim became a "super dad", holding their world up — but privately, he was in ruins.
"I'd get them into school and drag myself home and slam the door, shut the curtains, lie on the bed, cry, not eat — just wallow in a black cloud all day," he says.
"I felt it was going to be an endless journey of sadness."
Jim's parents eventually decided he needed a break; in May 2000 he reluctantly agreed to a holiday.
Jim went to the hotel pool — and sat down next to Tyler.
They hit it off, and kept in touch. They both felt something bigger than friendship, but Jim was full of doubt.
"I started to think, this is ridiculous. Like, this is a man for a start. I've got responsibilities. I've got kids. I can't do this," Jim says.
"And he was like, 'No, there's something strong here. I can't just walk away from you'."
They tried to map a future, but Jim wanted things to stay normal for the kids; being openly gay in an era of "massive homophobia" didn't feel like an option.
"He said, 'The only way this can work is if the house next door came up for sale," Tyler recalls.
That same day, a 'For Sale' sign was knocked into the yard next door.
"The exact day. You can't make this up," Tyler says.
Six months after they met, Tyler and Jim became neighbours.
"Behind closed doors we were living together, with the gardens and the houses shared," Jim says.
The kids knew Tyler as their dad's best friend, generous and fun.
Daisy was shocked when the truth eventually came out.
"I broke down. I thought my life was over, to be honest," she says.
"It took time to adjust. And I think moving to Australia made it easier for us."
A decade later, they were all living in Sydney, and Jim and Tyler were married.
"I see Tyler as a saviour of Dad because it brought him back to happiness," Daisy says.
The first signs of dementia appeared a few years before Jim's diagnosis: little errors at work, repeated conversations, being a bit forgetful.
But Jim worked a busy job flipping houses, and his GP put it down to stress.
"One day I went to my cardiologist and she was getting a bit pissed off because my phone was constantly going off," Jim says.
"She was like, 'Could you put it on silent?' And I had this blank; I couldn't think how to do it."
The cardiologist referred him to a memory clinic.
In 2022, at the age of 55, Jim was diagnosed with younger-onset Alzheimer's.
Jim's world suddenly became smaller. He gave up his driver's licence and retired from work. He spiralled into despair.
Finally, Tyler told him to "snap out of it" and stop wasting the now worrying about the future.
"I was so forceful with him because I want to enjoy that now with him, for as long as I can," Tyler says, fighting back tears.
Jim gave himself the weekend to wallow and started Monday with a fresh outlook.
"You can turn something sad and hard into something positive and upbeat. You just have to put your mind in focus and do it," he says.
He was given about 10 years, but nobody really knows how quickly it will develop.
Jim says his early diagnosis has been a gift because he can make time for things he would otherwise have put off; his bucket list has a lot of ticks on it.
He can also work to slow the disease: he takes medication, watches his diet, works with a trainer, swims every day and does yoga to relax his brain.
"I forget that he has dementia. There are times I have to remind myself because he is doing so well," son Harvey says.
Jim, who now lives in Brisbane, has become an advocate for Dementia Australia.
He co-hosts the Hold The Moment podcast, which shares stories about people living with dementia and their loved ones.
"It was like everything in his life has led to this moment," Millie says.
This is how he met Hamish, whose father had Parkinson's and Lewy body dementia.
"Going into this, I expected I was there to look after the co-host. The reality is it's actually me that needed help," Hamish says.
"I was feeling quite angry about dementia. It was not an easy ride looking after Dad."
Jim helped Hamish realise there was still room for fun and meaningful moments with his father.
"It adjusted what I did with Dad. As often as we could, we'd go for a swim at the ocean pool so that not everything we did together was centred around dementia," Hamish says.
"It was transformative."
Jim likens dementia to having layers of dust accumulating on his brain.
He gets lost in familiar places. He gets distracted easily. He struggles to sleep and has vivid nightmares, so he's exhausted all the time.
"In the dark of night is horrible. Your mind plays tricks on you," Jim says.
Jim can't protect his children like he did when their mum died — and they don't want him to.
"We're saying to him all the time: 'We're adults, we have kids of our own. We can look after you'," Millie says.
The family has spoken about what will happen when Jim inevitably goes downhill.
"The hardest conversations are about what it looks like when he doesn't remember us," Daisy says.
Jim has thought about euthanasia, but nothing has been decided yet.
"I don't know if it takes more strength to take control, or more strength to go where you're going to go," he says.
For now, though, he's focusing on what he loves: his husband, his children, his grandchildren, his advocacy.
"Dementia isn't all doom and gloom. I want to cram so much in," Jim says.
"I'm so full of life and full of love."
Watch Australian Story's Forget Me Not, 8pm, on ABCTV and ABC iview.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Daily Telegraph
2 hours ago
- Daily Telegraph
'It's like fauxtox!' The $66 face cream that women over 40 swear by
Don't miss out on the headlines from Lifestyle. Followed categories will be added to My News. I can't really explain it, but you know that fresh smell you get when you leave a really good facial? Or the lingering scent of essential oils on your skin after a relaxing massage? That's what it smells like. "It" being a new face cream I've been using and loving. And as it turns out, I'm not the only one. Let's rewind a little. Women over 40 - or even earlier for the really unlucky ones - have been speaking openly about perimenopausal symptoms affecting their everyday life more so than ever before. They're coming together in support, and even educating the clueless men in their lives about why we are sometimes so ragey about the way they're stacking the dishwasher. Want to join the family? Sign up to our Kidspot newsletter for more stories like this. Perimenopause symptoms suck Yes, there's the mood and menstrual cycle changes, as well as hot flushes, irritability, mood swings, night sweats, sleep disruption, and changes in your libido. But what about your skin? When discussing peri symptoms, no one seems to talk about how lifeless, blotchy, and puffy your skin can get. According to my GP, I'm "not there yet" but that's certainly news to my face! Ever since I hit 40, I've been blessed with the occasional outburst of adult acne, far too much pigmentation, and just general dullness. So when I heard that one of my favourite local brands had released a cream just for women approaching their menopause phase in life, you bet I wanted to give it a try. And before you ask... NO, this isn't sponsored! I genuinely want to share it with you. RELATED: The $52 moisturiser that banishes adult acne Antipodes' Jasmine Flower face cream retails at $66. Image: Supplied The $66 face cream for women approaching menopause New Zealand skincare brand, Antipodes, recently launched their Jasmine Flower Menopause Facial Cream (RRP $66, 60ml) - a day cream that targets women who are suffering from visible symptoms of perimenopause and full-blown menopause. It's silky, cooling, smells divine with the scent of jasmine (see notes above about the smell you get leaving a facial), and targets redness, fine lines and wrinkles. When I applied the cream for the first time, I was a little worried about the thickness - it had the same consistency as a 50+ sunscreen. But within seconds of rubbing it in, the white cream soaks into your skin, leaving it super moisturised and your face full of life. "Formulated for sensitive skin, it helps with visible signs of menopause such as redness, severe dehydration, hormonal blemishes, and signs of ageing, to smooth and balance your evolving complexion," the website description reads. Born and bread in New Zealand... just for your peri skin needs. Image: Supplied "Organic oat extract calms red, irritated, and sensitive skin. Peptides from chamomile and fermented jasmine flowers help relax lines and wrinkles. New Zealand avocado oil, with collagen boosting properties, fused with manuka honey to ease signs of ageing whilst reducing blemishes." I caught a glimpse of myself in the mirror a few hours after applying, and my face not only felt great, it made me look alive again! The redness and puffiness I woke up with were gone, and I was left with a radiant base that really needed nothing on top. It was like fauxtox in a jar! RELATED: What you need to know about perimenopause The women have spoken! Before launching the day cream, the Antipodes team conducted an independent clinical study with 50 women suffering from sensitive skin. After trialling it, 78% said the cream visibly calmed their irritated skin. Jennie is just one of those women who has seen a visible improvement after consistently using the cream for three weeks. "I have loved this product, it's not heavy but covers well and really left my skin feeling hydrated. I have three types of rosacea: in my eyes, the red skin one and papulopustular, and this cream has looked after all three," she praised. Jennie suffered from a heap of skin issues, which the cream seemed to settle. Image: Supplied Hanni also gave it a 5-star review, claiming she saw a "huge improvement" in her skin's moisture level. "My skin blotches are disappearing after only two weeks," she confessed. And the glowing (boom boom) reviews keep coming. "The plumpness and reduced tightness are game changers... My combination skin feels perfectly balanced—no excess oil, just smooth and hydrated," a fan wrote online. Another agreed: "This product is amazing - leaves your skin feeling and looking great. I'm sure my skin looked more youthful after using it. Love the scent too." "Lovely and smooth, my skin loves it," another fan added. Try it out for yourself! Grab a jar from Priceline, David Jones, Chemist Warehouse, Adore Beauty, Healthylife, Nourished Life as well as independent pharmacies and health shops across Australia. Just don't expect it to calm your nerves around your annoying spouse.. that will still continue! Originally published as 'It's like fauxtox!' The $66 face cream that women over 40 swear by

News.com.au
4 hours ago
- News.com.au
Health Check: A pancreatic cancer ‘cure' has been elusive, but Amplia may have cracked the nut
Amplia shares soar almost 50% on news of a 'complete response' in a patient with metastasised pancreatic cancer Syntara and Kazia also report progress with their cancer drug candidates Emvision pockets $5 million of non-dilutive grant funding Has Amplia (ASX:ATX) cured pancreatic cancer, one of the deadliest tumour types? The drug developer reports a 'pathological complete response' in an advanced (metastatic) pancreatic cancer patient – an 'extremely rare' event. A pathological complete response means there are no signs of cancer in tissue examined by a pathologist following surgical removal. The treatment appeared to have reduced the tumour to a size where both the primary tumour in the pancreas and secondary liver tumours could be excised. Amplia's drug candidate AMP-945 (narmafotinib) is a focus kinase (FAK) inhibitor. FAKs are not cuss words but a type of protein overexpressed in pancreatic cancers. Dubbed Accent, Amplia's trial uses narmafotinib in combination with standard chemotherapy gemcitabine. The company is carrying out the phase 1b/2a trial at seven local sites and five in South Korea. The first stanza (1b) already has assessed dosing safety and tolerability The company notes about 5% of patients with non-metastatic pancreatic cancer achieve a pathological compete response. The bar for cancers that have spread is much higher. 'This is wonderful news for the patient and the clinical team involved,' Amplia CEO Dr Chris Burns says. 'We firmly believe this outcome further demonstrates the promising activity narmafotinib, on top of standard-of-care, is showing in treating advanced pancreatic cancer.' While one swallow doesn't make a summer, investors pushed Amplia shares as much as 47% higher before profit takers moved in. Syntara's blood cancer program looks the goods Amplia chief Chris Burns co-developed the myelofibrosis (blood cancer) drug Ojjaara, one of the few home-grown remedies to be approved by the US Food and Drud Administration (FDA). Can Syntara (ASX:SNT) follow suit? The company reports further data from its phase II trial, evaluating its drug candidate SNT-5505 in combo with the standard-of-care drug ruxolitinib. The patients had been treated with ruxolitinib for at least three years, so had enhanced symptoms such as enlarged spleen size and blood counts 'indicative of high disease burden.' The results showed eight of eleven evaluable patients (73%) achieved a reduction of more than 50% at 24 weeks. This was measured by a standard gauge called TSS50. The patients achieved a median improvement of 39%. Four out of nine patients (44%) had a spleen volume reduction of 25% at week 24 or beyond. The ongoing trial enrolled 16 patients with intermediate or high-risk myelofibrosis, for 52 weeks of treatment. However, five dropped out by the 24-week mark, a 'withdrawal rate consistent with that seen in other myelofibrsis studies of patients with similar disease severity." Eight patients reaching 38 weeks showed an average 56% reduction in symptoms. Of these, Five patients reaching 52 weeks showed a 63% decline. The company plans to release the final study results after the September quarter, when the remaining three patients have completed their treatment. Syntara intends to meet with the FDA in the September quarter to discuss the design of a pivotal phase 2c/3 study. The company announced the results on Friday and aired them at the weekend's European Hematology Association conference in Milan. Kazia's cancer news from the Nasdaq Further afield, the Nasdaq listed and formerly ASX-domiciled Kazia last week said its immunotherapy candidate paxalisib showed 'anti-tumour activity in advanced breast cancer'. In collaboration with the Queensland Institute of Medical Research (QIMR) Berghofer, Kazia is carrying out a 24-patient, phase Ib trial in combo with the standard-of-care pembrolizumab (Keytruda). The Sydney-based Kazia licensed the tech from the QIMR. The company said the data provided 'strong scientific and translational rationale for continued development of paxalisib as part of immunotherapy-based regimens.' The dual-listed Kazia delisted from the ASX last November, to reduce costs. The experience of ASX biotechs joining the Nasdaq has been patchy, to put it mildly. But Kazia shares last week more than doubled on the news. The pain of Mayne stays mainly on display Mayne Pharma (ASX:MYX) will forge ahead with a planned shareholder meeting to approve its takeover scheme of arrangement, despite receiving a second 'dear John' letter from suitor Cosette. Mayne says the correspondence – almost certainly not written on rose-scented parchment – affirms that Cosette intends to terminate the scheme implementation deed (SID) on the grounds of alleged breaches. It maintains Cosette has 'no lawful basis' to terminate the SID. So, as it stands Mayne shareholders will file into Melbourne's Intercontinental Hotel on Wednesday to vote on an offer that a reluctant suitor has no intention of executing. With no whiff of rapprochement, this one is headed for the courts. Emvision wins $5 million government grant There's no better funding than the non-dilutive variety, as EMvision Medical Devices (ASX:EMV) attests. The feds have awarded Emvision a $5 million federal government grant, to further the development of its First Responder portable brain scanner. The funds are by way of an Australian Government Industry Growth Program (IGP) Commercialisation and Growth Grant. First Responder distinguishes between bleed and clot strokes at the scene and is designed to be used by ambulances and by paramedics. The device should shorten diagnosis time – a crucial element in the patient getting the right treatment. 'First Responder … is a genuine world first product with potential to transform the landscape of pre-hospital stroke and traumatic brain injury care,' Emvision chief Scott Kirkland says. '… quite simply, if we can help save time, we can help save lives and reduce disability.' As of the end of March, Emvision had $12.5 million of cash and expected $800,000 of funding from the Australian Stroke Alliance this financial year. Heramed in maternity monitoring collab Still on non-dilutive funding, foetal monitoring device developer HeraMED (ASX:HMD) has partnered with RMIT University (RMIT) and the Digital Health Cooperative Research Centre in a research partnership. The $1.245 million project will delve into better ways to deliver maternity care for culturally and linguistically diverse women. As is the way in the modern world, the project involves refining AI-based predictive health models and tools. This is based on monitoring and collecting data on 200 pregnant women. 'The initiative will use a combination of clinical, biometric, lifestyle and genetic data, with a focus on diversity, inclusion, and clinical applicability," Heramed says. Heramed is contributing $250,000 over the 18-month project and the other parties are contributing the rest via grant funding. 'With 51% of Australians having at least one parent born overseas, the need for culturally informed healthcare is critical and relevant,' says Heramed CEO Anoushka Gungadin.

News.com.au
5 hours ago
- News.com.au
Great gender divide playing out in kitchens across the country
It's the great gender divide playing out in kitchens across the country. When it comes to cooking dinner – the burden of preparing the nightly meal still overwhelmingly falls on women. The Dinner Heroes survey conducted by the Growth Intelligence Centre (GIC) found 72 per cent of women said they are solely responsible for cooking family dinners, compared with 49 per cent of men who said it fell on them. But it's Aussie dads who are rising to the occasion – with two in five saying they are solely responsible, and almost the same amount saying they share nightly cooking duties. And for Senior Lecturer in Public Health Dr Catherine Fleming, that is music to her ears. 'The family unity and the family dynamic are so important to having children learn to eat well and grow well,' Dr Fleming from Western Sydney University told 'There is so much evidence to show that that modelling (of children seeing their parents cooking) and especially coming from the dads is so important in helping a really healthy wellbeing environment within the home, which can contribute to lots of long-term health outcomes for these families that cook together, eat together, nourish together. 'For me, that's a fundamental part of learning and modelling those healthy skills,' Dr Fleming said. 'And young boys can see that 'hey Dad can cook really well, he is cooking great food that we can all eat and all share'. 'It doesn't just sit on the mum to then also choose a meal prep,' Dr Fleming said. 'I think it's a really important thing they get involved. If the dad's cooking he's probably planned what they're going to eat, shopped in the shops and got something on the way home. 'So seeing that whole process and understanding that process is really important for young girls and boys alike to see that dad's contributing and it's a family unit that's really sitting down to eat that meal. 'Food isn't just something that we eat that has no purpose in life. it plays a major role for all of us in the family,' she said. While an overwhelming number of Australians (85 per cent) agreed sharing meals is important, the survey found just over half eat at the dining table, while more than a quarter said the couch was where they ate dinner most often. One in five Gen Zers – those aged between 13 and 28 – who lived at home with their parents said they often ate their dinner in their bedrooms, with one in four living in four living in a share house said they did the same. Social researcher, author and Gen Z expert Dr Claire Madden said where families once gathered around the TV, technology now is so individualised. 'Gen Z is that one generation that has grown up on individualised devices and are accustomed to being in their own virtual world 24/7,' Dr Madden told 'It's the shift from when the TV was at the centre of the family home. 'But what we need to be aware of is that young people are craving connection and meaningful connection, and being on their devices is not satisfying deeper human connections,' Dr Madden said. Dr Madden said it was up to all of us to 'help shape the family culture' that we want, and can do this by encouraging putting away devices at meal times. 'What we need to consider is actually healthy disconnecting because these young people may not be aware of the process of what it took to make that meal,' she said. 'We can change these patterns in our households. We can say no devices during dinner. You can have it before and after dinner. 'You can take it in turns cooking and participating in the preparation … create an offline experience that is more fulfilling and engaging'. She said cooking and meal prepping are a great way to build connections between generations and give Gen Zers the deeper connections they crave. Dr Madden said young Australians like 'tactile, hands-on learning and cooking is an excellent way that produces results they can measure and see'. 'They can then take pictures of what they've cooked and share it online and on social media and show their achievement'. And when it came to time spent in the kitchen, the survey found one in four Aussies spent one to two hours cooking dinner each week, with a third (29 per cent) of Gen Z and Millennials admitting to spending between three and four hours a week cooking. The survey of 2083 Australians found Aussies have three or four go-to meals they cook each week, with one in five Gen Zers and Millennials more likely to cook something new for dinner two times a week, compared with 13 per cent of Gen Xers and 15 per cent of Boomers. The dinner experts at have teamed up with Coles to create 20 brand-new, flavour-packed Dinner Heroes recipes that are quick, simple and delicious. 'Some meals actually taste better the next day once the flavours mellow … think curries, stews, tomato-based sauces and soups,' Digital Food Director Amira Georgy told 'There are so many benefits to freezing meals, the biggest is that it saves you so much time and effort. On busy weeknights, having a ready-made meal to pull from the freezer is a godsend. It eliminates the need for last-minute cooking or resorting to expensive (and often less healthy) takeaway,' Ms Georgy said. One in four women and almost one in five men said they spent less than 15 minutes eating dinner, while unsurprisingly families with children under 12 said they spend between 30 and 45 minutes.